Cargando…

Clinical assessment of hepatic de novo lipogenesis in non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease (NAFLD) is heralded as the next big global epidemic. Hepatic de novo lipogenesis (DNL), the synthesis of new fatty acids from non-lipid sources, is thought to play a pivotal role in the development of NAFLD. While there is currently no NAFLD-specific therapeutic age...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paglialunga, Sabina, Dehn, Clayton A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027077/ https://www.ncbi.nlm.nih.gov/pubmed/27640119 http://dx.doi.org/10.1186/s12944-016-0321-5

Ejemplares similares

The Role of Dietary Sugars and De novo Lipogenesis in Non-Alcoholic Fatty Liver Disease
por: Moore, J. Bernadette, et al.
Publicado: (2014)

Fatty Liver Due to Increased de novo Lipogenesis: Alterations in the Hepatic Peroxisomal Proteome
por: Knebel, Birgit, et al.
Publicado: (2019)

Fructose Consumption, Lipogenesis, and Non-Alcoholic Fatty Liver Disease
por: ter Horst, Kasper W., et al.
Publicado: (2017)

Raphani Semen (Raphanus sativus L.) Ameliorates Alcoholic Fatty Liver Disease by Regulating De Novo Lipogenesis
por: Park, Woo Yong, et al.
Publicado: (2021)

Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers
por: Rosqvist, Fredrik, et al.
Publicado: (2019)

A Narrative Review on the Role of AMPK on De Novo Lipogenesis in Non-Alcoholic Fatty Liver Disease: Evidence from Human Studies
por: von Loeffelholz, Christian, et al.
Publicado: (2021)

Tcf7l2 in hepatocytes regulates de novo lipogenesis in diet-induced non-alcoholic fatty liver disease in mice
por: Lee, Da Som, et al.
Publicado: (2023)

Hepatic saturated fatty acid fraction is associated with de novo lipogenesis and hepatic insulin resistance
por: Roumans, Kay H. M., et al.
Publicado: (2020)

Adding to the spectrum of insulin sensitive populations for mixed meal tolerance test glucose reliability assessment
por: Paglialunga, Sabina, et al.
Publicado: (2016)

Trimetazidine improves hepatic lipogenesis and steatosis in non-alcoholic fatty liver disease via AMPK-ChREBP pathway
por: Zhang, Ying, et al.
Publicado: (2020)

Gene expressions of de novo hepatic lipogenesis in feline hepatic lipidosis
por: Valtolina, Chiara, et al.
Publicado: (2019)

Inhibition of fatty acid synthase with FT‐4101 safely reduces hepatic de novo lipogenesis and steatosis in obese subjects with non‐alcoholic fatty liver disease: Results from two early‐phase randomized trials
por: Beysen, Carine, et al.
Publicado: (2020)

Growth Hormone Inhibits Hepatic De Novo Lipogenesis in Adult Mice
por: Cordoba-Chacon, Jose, et al.
Publicado: (2015)

Sex Differences in Hepatic De Novo Lipogenesis with Acute Fructose Feeding
por: Low, Wee Suan, et al.
Publicado: (2018)

Inhibiting CB1 receptors improves lipogenesis in an in vitro non-alcoholic fatty liver disease model
por: Shi, Dongmei, et al.
Publicado: (2014)

Using total plasma triacylglycerol to assess hepatic de novo lipogenesis as an alternative to VLDL triacylglycerol
por: Hodson, Leanne, et al.
Publicado: (2020)

Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
por: Green, Charlotte J, et al.
Publicado: (2020)

The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice
por: Ideta, Takayasu, et al.
Publicado: (2015)

RF32 | PSUN44 CARF Regulates Non-Alcoholic Fatty Liver Diseases (NAFLD) by Controlling ER Stress and Lipogenesis in Hepatic Cells.
por: Friedman, Theodore, et al.
Publicado: (2022)

Modeling fructose-load-induced hepatic de-novo lipogenesis by model simplification
por: Allen, Richard J, et al.
Publicado: (2017)

Acute intermittent hypoxia drives hepatic de novo lipogenesis in humans and rodents
por: Hazlehurst, Jonathan M., et al.
Publicado: (2022)

De Novo Lipogenesis Products and Endogenous Lipokines
por: Yilmaz, Mustafa, et al.
Publicado: (2016)

Associations of Erythrocyte Fatty Acids in the De Novo Lipogenesis Pathway with Proxies of Liver Fat Accumulation in the EPIC-Potsdam Study
por: Jacobs, Simone, et al.
Publicado: (2015)

Reduction of De Novo Lipogenesis Mediates Beneficial Effects of Isoenergetic Diets on Fatty Liver: Mechanistic Insights from the MEDEA Randomized Clinical Trial
por: Costabile, Giuseppina, et al.
Publicado: (2022)

Metformin maintains intrahepatic triglyceride content through increased hepatic de novo lipogenesis
por: Green, Charlotte J, et al.
Publicado: (2022)

Effects of hepatic mitochondrial pyruvate carrier deficiency on de novo lipogenesis and gluconeogenesis in mice
por: Yiew, Nicole K.H., et al.
Publicado: (2023)

Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
por: Yao, Zhenyu, et al.
Publicado: (2023)

Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
por: Opazo-Ríos, Lucas, et al.
Publicado: (2022)

Desaturation index versus isotopically measured de novo lipogenesis as an indicator of acute systemic lipogenesis
por: Harding, Scott V, et al.
Publicado: (2015)

Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients
por: Lawitz, Eric J., et al.
Publicado: (2022)

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation
por: Wu, You, et al.
Publicado: (2021)

Expanding Roles of De Novo Lipogenesis in Breast Cancer
por: Simeone, Pasquale, et al.
Publicado: (2021)

DAXX drives de novo lipogenesis and contributes to tumorigenesis
por: Mahmud, Iqbal, et al.
Publicado: (2023)

miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease
por: Long, Jun-Ke, et al.
Publicado: (2019)

De novo non-alcoholic fatty liver disease after pancreatectomy: A systematic review
por: Shah, Parth, et al.
Publicado: (2022)

Short-Term Growth Hormone Administration Mediates Hepatic Fatty Acid Uptake and De Novo Lipogenesis Gene Expression in Obese Rats
por: Likitnukul, Sutharinee, et al.
Publicado: (2023)

Hepatic steatosis risk is partly driven by increased de novo lipogenesis following carbohydrate consumption
por: Sanders, Francis W. B., et al.
Publicado: (2018)

Skeletal Muscle Insulin Resistance Promotes Increased Hepatic De Novo Lipogenesis, Hyperlipidemia, and Hepatic Steatosis in the Elderly
por: Flannery, Clare, et al.
Publicado: (2012)

LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease
por: Liu, Jun, et al.
Publicado: (2019)

De novo lipogenesis in the liver in health and disease: more than just a shunting yard for glucose
por: Sanders, Francis W. B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pjk1gj1kjaoql89skukobr45d6